CTRI/2018/04/013100
Completed
未知
International Diabetes Management Practices Study - IDMPS Wave 7
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- DiabetesHealth Condition 2: E088- Diabetes mellitus due to underlying condition with unspecified complications
- Sponsor
- Sanofi India Limited
- Enrollment
- 8426
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.All male and female adult people (who have attained his/her majority) diagnosed with type 1 or type 2 diabetes, visiting the physician during the recruitment period of the crossâ??sectional study, up to the number of patients allocated to the physician.
- •2\. Written informed consent.
Exclusion Criteria
- •1\. Concomitant participation to a clinical trial.
- •2\. Previous participation in this study.
- •3\. Current temporary insulin therapy (gestational
- •diabetes, surgery, pancreas cancer).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
IDMPS will be an international, multicenter, observational study with a cross-sectional study to assess current practices in the management in the patients with type 1 and type 2 diabetes mellitus non-interventional on therapeutic strategyHealth Condition 1: null- Type 1 and Type 2 Diabetes MellitusHealth Condition 2: E109- Type 1 diabetes mellitus without complicationsCTRI/2012/02/002407Sanofi Synthelabo I Ltd12,519
Active, not recruiting
Not Applicable
Study of Diabetes treatment management across region by different investigator for both type 1 & type 2 diabetes patientsHealth Condition 1: E089- Diabetes mellitus due to underlying condition without complicationsCTRI/2019/03/017914Sanofi India Limited
Completed
Not Applicable
Diabetes care Implementation StudyDiabetes Mellitus type two (DM2)Nutritional, Metabolic, EndocrineDiabetesISRCTN21523044niversity Medical Centre Utrecht (UMCU) (The Netherlands)3,500
Recruiting
Not Applicable
Multicenter Investigation for Diabetes mellitus in AtheroSclerosisPatients admitted to the participating institution for 1. Acute myocardial infarction within 24 hours after symptom onset 2. Angina pectoris requiring PCI 3. Heart failure 4. Atrial fibrillation undergoing catheter ablation 5. Cerebral infarction 6. Transient ischemic attackJPRN-UMIN000010039ational Cerebral and Cardiovascular Center5,000
Completed
Not Applicable
Diabetes UK StudyTopic: Diabetes Research NetworkSubtopic: Type 2Disease: Nephropathy, Cardiovascular disease, Hypertension, Dyslipidaemia, Diabetic Control, Multiple complicationsNutritional, Metabolic, EndocrineChronic kidney diseaseISRCTN85900874South Tees Hospitals NHS Foundation Trust (UK)600